Posted on 11월 26, 202411/26/24
The Importance of Quality-of-Life Metrics in mCRPC
Posted on 11월 6, 202411/6/24
Adherence Redefined: Evolving Approaches to Adherence in Oncology Clinical Pathways
Posted on 11월 4, 202411/4/24
Comparing First-Line Treatments for mCRPC: Insights From a Comprehensive NMA
Posted on 9월 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on 6월 5, 20246/5/24
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
Posted on 3월 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
Posted on 7월 18, 20237/18/23
Specialty Pharmacies are Ready for the Biosimilar Boom. Are you?
Posted on 7월 13, 20237/13/23